- Active not recruitingPHASE1
A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL)
This study is testing new combinations of drugs for a type of blood cancer called Non-Hodgkin Lymphoma. It's for people whose lymphoma has come back or hasn't responded to previous treatments. The main goal is to find a safe and effective dose of these new medications.
For: Lymphoma, Non-HodgkinAustralia · Spain · Taiwan - Enrolling by invitationPHASE1
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
This study helps us understand the long-term safety of new treatments for certain cancers like leukemia and lymphoma. People who have already been in an earlier drug trial for these conditions will continue to be monitored to see how they respond over time.
For: Leukemia, Myeloid, Acute · Leukemia, Lymphocytic, Chronic, B-Cell · Lymphoma, Non-HodgkinBelgium · France · Georgia